Literature DB >> 2505207

Ocular changes in the mucopolysaccharidoses after bone marrow transplantation. A preliminary report.

C G Summers1, R L Purple, W Krivit, R Pineda, G T Copland, N K Ramsay, J H Kersey, C B Whitley.   

Abstract

Metabolic correction and physiologic response were evaluated after bone marrow transplantation in mucopolysaccharidosis. Eleven patients were prospectively evaluated to determine the effect of bone marrow transplantation on the progressive ocular manifestations of these disorders. Follow-up of 0.6 to 2.8 years after successful donor stem cell engraftment showed that some patients had slow clearing of the corneal clouding, reduction of intracytoplasmic inclusions in the conjunctiva, resolution of optic nerve edema, and stabilized or improved retinal function as determined by electroretinography. These preliminary results suggest that early bone marrow transplantation may alter some of the progressive ophthalmic characteristics of the mucopolysaccharidoses. Long-term follow-up is necessary to determine if these early alterations in the ocular features are predictive of a prolonged functional improvement in the visual status.

Entities:  

Mesh:

Year:  1989        PMID: 2505207     DOI: 10.1016/s0161-6420(89)32795-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  10 in total

1.  Glaucoma in siblings with Morquio syndrome.

Authors:  M Cahane; G Treister; F A Abraham; S Melamed
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

2.  Anterior segment OCT imaging in mucopolysaccharidoses type I, II, and VI.

Authors:  T Y Ahmed; A M J Turnbull; N F Attridge; S Biswas; I C Lloyd; L Au; J L Ashworth
Journal:  Eye (Lond)       Date:  2014-01-03       Impact factor: 3.775

3.  A novel explanation of corneal clouding in a bone marrow transplant-treated patient with Hurler syndrome.

Authors:  Ching Yuan; Erick D Bothun; David R Hardten; Jakub Tolar; Linda K McLoon
Journal:  Exp Eye Res       Date:  2016-05-26       Impact factor: 3.467

Review 4.  Trends in haematopoietic cell transplantation for inborn errors of metabolism.

Authors:  Jaap Jan Boelens
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

5.  Intrastromal Gene Therapy Prevents and Reverses Advanced Corneal Clouding in a Canine Model of Mucopolysaccharidosis I.

Authors:  Keiko Miyadera; Laura Conatser; Telmo A Llanga; Kendall Carlin; Patricia O'Donnell; Jessica Bagel; Liujiang Song; Joanne Kurtzberg; R Jude Samulski; Brian Gilger; Matthew L Hirsch
Journal:  Mol Ther       Date:  2020-04-11       Impact factor: 11.454

6.  Does enzyme replacement therapy influence the ocular changes in type VI mucopolysaccharidosis?

Authors:  Susanne Pitz; Olufunmilola Ogun; Laila Arash; Elke Miebach; Michael Beck
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-01-22       Impact factor: 3.117

7.  AAV Gene Therapy for MPS1-associated Corneal Blindness.

Authors:  Melisa Vance; Telmo Llanga; Will Bennett; Kenton Woodard; Giridhar Murlidharan; Neil Chungfat; Aravind Asokan; Brian Gilger; Joanne Kurtzberg; R Jude Samulski; Matthew L Hirsch
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

Review 8.  Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement.

Authors:  Christiane S Hampe; Jacob Wesley; Troy C Lund; Paul J Orchard; Lynda E Polgreen; Julie B Eisengart; Linda K McLoon; Sebahattin Cureoglu; Patricia Schachern; R Scott McIvor
Journal:  Biomolecules       Date:  2021-01-29

9.  Ocular Tolerability and Immune Response to Corneal Intrastromal AAV-IDUA Gene Therapy in New Zealand White Rabbits.

Authors:  Liujiang Song; Jacquelyn J Bower; Telmo Llanga; Jacklyn H Salmon; Matthew L Hirsch; Brian C Gilger
Journal:  Mol Ther Methods Clin Dev       Date:  2020-05-22       Impact factor: 6.698

10.  Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure.

Authors:  J J Boelens; R F Wynn; A O'Meara; P Veys; Y Bertrand; G Souillet; J E Wraith; A Fischer; M Cavazzana-Calvo; K W Sykora; P Sedlacek; A Rovelli; C S P M Uiterwaal; N Wulffraat
Journal:  Bone Marrow Transplant       Date:  2007-05-28       Impact factor: 5.483

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.